Small Cap Feast

Small Cap Feast – 29 July 2019

Dish of the Day:

Mustang Energy PLC (MUST), a special purpose acquisition company formed to acquire oil and gas projects in developed jurisdictions, has joined the Standard List of the main market raising £0.75m at 10p.

Off the Menu:

No Leavers Today

What’s Cooking in the IPO Kitchen?

Main Market

Interswitch, a Nigeria-based payments firm, has hired advisers to resurrect plans for a stock-market listing in London and Lagos later this year, which may value the financial technology company at $1.3bn to $1.5bn.


Roxi Music UK music streaming service plans London IPO as it goes up against Spotify. They have appointed investment bank Arden Partners for an initial public offering (IPO) on the London Stock Exchange later this year.


Freyherr International Group PLC the Medicinal Cannabis holding company established in 2016,  is planning to list on the NEX exchange on the 13 August

Breakfast Buffet

Echo Energy (ECHO) 2.70p £12.19m

Echo Energy, the Latin American-focused upstream oil and gas company, announces that initial seismic processing of  data from the 3D seismic survey conducted over the 414km2 eastern cube (Chiripa Oeste) at Tapi Aike, its licence in Argentina’s Santa Cruz province is now complete.  

Analysis on this processed data is currently being conducted by a team of geophysical specialists.  Early interpretations highlight a similar amplitude feature that was recognised during the interpretation of the 2D seismic. Current analysis is focused on the geological understanding of the feature identified in the seismic data. This will provide Echo, and its partner and licence operator Compañía General de Combustibles S.A., further input into prospect generation on the eastern survey as it progresses towards identifying drill locations on the block.

As announced on 19 June 2019, 3D seismic on the western cube (Travesia de Arriba) of 790 km2 is currently being processed by Seismic Prospect S.R.L in Buenos Aires following the earlier completion of seismic acquisition. Technical work remains on track and an update will be provided to investors in due course.

The continuing positive progression of the seismic programme on schedule represents important steps in the delivery of the exploration campaign targeting the spudding of wells during Q4 2019.

Directa Plus (DCTA) 83.00p £42.17m

Directa Plus, a leading producer and supplier of graphene nanoplatelets based products for use in consumer and industrial markets, announces that it has been awarded a supply and service contract to treat and recover crude oil from producing wells onshore Europe. The Award, commencing on 1 Aug 2019, is to treat several thousand cubic meters of sludges and by-products for a value of approximately €0.15m over the next six months, using the Company’s Grafysorber® technology.  Directa Plus will provide a full service to the customer, an international oil and gas company, supplying a mobile treatment unit and operating the recovery process.

Directa Plus and the customer expect that the application of the Grafysorber® technology will both improve the production process and potentially reduce costs through recovering crude oil from sludges and water associated with extraction and avoiding disposal as an untreated waste. In addition, the treatment will improve the quality of the water injection to stimulate production which will help to meet environmental regulations and reduce usage of water resources.

The Award is in line with the Company’s previously announced strategy to offer a full decontamination and recovery service for its Grafysorber® pollutant adsorber product to international oil and gas and marine markets in order to capture significant additional value for shareholders.

Eden Research (EDEN) 10.85p £21.44m

Eden Research, the  company that develops and supplies breakthrough biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries, announced that its commercial partner, Sumi Agro France, has received a 120 day “emergency use” authorisation for Eden’s fungicide, Mevalone, from the French authorities for the treatment of storage diseases on apples.  Such “emergency” authorisations are allowed by EU member states when local regulatory authorities judge that they are needed in the local market in order to meet the requirements of growers in the absence of suitable commercially-available alternatives.  

Sumi Agro has been selling Mevalone in France since receiving approval for the sale and use of Mevalone for the treatment of botrytis on table and wine grapes in Jan 2017. This 120-day derogation represents the first authorisation for the use of Mevalone on apples and for the treatment of post-harvest storage diseases. Under this 120-day derogation, Sumi Agro will sell Mevalone to apple producers who will apply Mevalone just prior to harvest.  France is one of the top ten producers of apples globally and is the third largest producer in Europe.  France is also the fifth largest exporter of apples globally by value.

i-nexus Global (INX) 26.50p £10.20m

i-nexus Global, a leading provider of cloud-based Strategy Execution software solutions designed for the Global 5000, provided an update on trading for the year ending 30 September 2019.

At the time of the Interim Results, released in May, the Board anticipated an acceleration in sales in the second half of the year. While the Group has secured a number of new sales in Q3 and the pipeline of opportunities is large and growing, these have not converted at the rate required to meet the Board’s revenue expectations for the financial year as a whole.  

Due to careful planning around investment, the EBITDA for the year is expected to be in line with current expectations; however both Total Recognised Revenue and closing Cash balances will be below expectations. As at 30 June 2019, the Company had cash of £3.1m and the Board is comfortable that, with a continued focus on costs, the business retains sufficient funding to execute on its growth strategy.

Whilst the slower than anticipated rate of conversion is disappointing, the Board remains confident that the strategy being pursued by the Group is right to support the acceleration of growth anticipated in future periods. The increased size and experience of the sales team is driving a growing pipeline of opportunities and improving the proportion of upsell opportunities to existing customers.

YouGov (YOU) 562p £559.04m

YouGov, the international research data and analytics group, announced a pre-close trading statement for the full year ending 31 July 2019.

We are pleased to report that the Group’s trading for the year ending 31 July 2019 is now expected to be comfortably ahead of expectations for the year. With these results, YouGov has achieved another year of strong revenue and operating profit growth. Notably, revenue has continued to progress substantially ahead of the global market research sector.  

This year, in line with our strategy and five-year plan, Data Products & Services continued its rate of excellent growth, and remains a strong contributor to profit, while Custom Research achieved growth rates above the industry average. YouGov continues to expand into new geographies – with organic operations in Canada and Mexico established during the year – and has experienced growth across all regions, with the core target markets of the UK and US remaining key drivers. As with previous years, while meeting our targets we have continued to invest throughout the period in our business to support further growth, with a particular focus on our technology and new products.

Cora Gold Limited (CORA) 6p £5.51m

Cora Gold, the West African focused gold exploration company, announced that recent oxide assay results have demonstrated an extension at depth, of high-grade gold mineralisation at the Zone A prospect at the Sanankoro Gold Discovery, Southern Mali.

Oxide assay results from two Reverse Circulation (‘RC’) drill holes demonstrate depth extension of gold mineralisation to 90-100m from surface

Grades returned included:

27m @ 2.43 g/t Au

36m @ 2.40 g/t Au

Wide zone of gold mineralisation identified within 250m long high-grade gold zone at the Zone A prospect, which appears to plunge moderately to the north, providing a future exploration target.

Drilling stage of the current programme has now been completed in Q3 2019 at the Sanankoro Gold Discovery

Assay results upcoming include a 212m orientated core hole completed at Zone A to test for sulphide gold mineralisation at depth

Europa Oil & Gas (EOG) 3.20p £14.23m

Europa Oil & Gas, the UK and Ireland focused oil and gas exploration, development and production company, notes today’s update from Egdon Resources that North Lincolnshire Council has withdrawn its case in respect of the upcoming appeal against the refusal of planning consent by the Council’s Planning Committee for the development of the Wressle Oil Field.  This follows a closed meeting held on 17 July 2019 during which the Council elected not to present evidence at the Public Inquiry that is scheduled to hear the Appeal on 5 Nov 2019.

Europa has a 30% working interest in licence PEDL 180 in the East Midlands which holds the Wressle oil discovery, alongside Egdon (operator, 30%), Union Jack Oil (27.5%), and Humber Oil & Gas Limited (12.5%).

The withdrawal of the Council’s case in respect of the Appeal remains subject to the agreement of acceptable planning conditions. The Partners welcome the Council’s decision and look forward to continuing supporting Egdon, in its capacity as operator of the Licence, as it seeks to obtain planning permission via appeal and prepares to present the case for the development of the Wressle Oil Field to the independent professional Planning Inspector in Nov 2019.

Angus Energy (ANGS) 1.50p £7.44m

Angus Energy announced that it has submitted to the National Grid a ‘Connection Application’ for direct entry to the National Transmission System (“NTS”) from the Company’s Saltfleetby Gas Field. The application commits Angus to a spend of £75,000 and is a significant milestone in the Company’s goal to re-commence commercial gas production from the field.

A detailed feasibility study will now begin to identify the most suitable tie-in location to the existing NTS connection point at the Theddlethorpe terminal. Furthermore, this study will include detailing equipment requirements for gas processing and assessing pipeline routes into the NTS.

“By submitting this application we set in motion a professionally and technically demanding process to re-establish safe connection and commercial flow of gas from the Saltfleetby Gas Field into the National Transmission System.  We will carefully update shareholders with the timetable and milestones in this process as they become known to us.”

Harvest Minerals (HMI) 4.90p £9.11m

Harvest Minerals, the fertiliser producer, announced that the first Strategic Meeting for Soil Remineralisers and New Agriculture, organised by the Company at the Centro Universitário de Patos de Minas (‘UNIPAM’) in Brazil, was a huge success.  

Journalists from Campo & Negócios, the leading agricultural magazine in Minas Gerais, attended the event and published an article, which is available on its own website and Harvest’s website.

Aukett Swanke Group (AUK) 1.68p £2.68m

Aukett Swanke, the international group of architects, interior designers and engineers, informed shareholders that it has been awarded the annual City Heritage Award for a record breaking fourth time. This year the prize was presented by the Lord Mayor for the project at Ten Trinity Square developed by the Reignwood Group. This encompassed the provision of the new luxury Four Seasons Hotel within the refurbished iconic building which was originally erected as the Headquarters of the Port of London Authority in 1922. The award is jointly nominated by the City Heritage Society and The Worshipful Company of Painter-Stainers and is given to the best Conservation or Refurbishment project in the City of London.

Head Chef:

Derren Nathan
0203 764 2344

*A corporate client of Hybridan LLP


This document, which does not constitute research, has been issued by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to any such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific person or entity and is not a personal recommendation to any such person or entity. Recipients should reach an individual investment decision, based upon their respective financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.

The information contained in this document is based on materials and sources that are believed to be reliable; however, such information has not been independently verified and therefore it is not possible to confirm such information as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information contained in this document, nor should it be relied upon as such.

The content of this document includes market commentary and other information which we have prepared in relation to the company referred to in this document, which is our broking client. The provision of this document to you constitutes a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of Regulation 600/2014/EU (MIFID II Regulation).

Any and all opinions expressed are current as of the date appearing on this face of this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.

This document should not be relied upon as being an independent or impartial view of the subject matter and, for the avoidance of doubt, constitutes non-independent research (as such term is defined in the Financial Conduct Authority’s Conduct of Business Sourcebook to reflect the requirements of the MIFID II Regulation and Directive 2014/65/EU (known as MIFID II)). The individuals who prepared this document may be interested in shares in the company concerned and/or other companies within its sector, may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.

In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are each a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority’s Conduct of Business Sourcebook) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as relevant persons). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority’s Conduct of Business Sourcebook.

Neither this document, nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom, the United States or any other jurisdiction in any part of the world.

Where possible this document is made available to all relevant recipients at the same time. Dissemination of research by Hybridan LLP is monitored to ensure that it is only provided to relevant persons. Research prepared by Hybridan LLP is not intended to be received and/or used by any person who is a retail client.

Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.

This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.

MIFID II status of Hybridan LLP research
The cost of production of our corporate research is met by retainers from our corporate broking clients. In addition, from time to time we issue further communications as market commentary (such as our daily newsletter, Small Cap Breakfast), which we consider to constitute a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of the MIFID II Regulation.

Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.

If you would like to unsubscribe, please email with “unsubscribe me”.